108 related articles for article (PubMed ID: 7996539)
1. Cholinergic agents structurally related to furtrethonium. 2. Synthesis and antimuscarinic activity of a series of N-[5-[(1'-substituted-acetoxy) methyl]-2-furfuryl]dialkylamines.
Feriani A; Gaviraghi G; Toson G; Mor M; Barbieri A; Grana E; Boselli C; Guarneri M; Simoni D; Manfredini S
J Med Chem; 1994 Dec; 37(25):4278-87. PubMed ID: 7996539
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic agents structurally related to furtrethonium. 3. Synthesis and antimuscarinic activity of a series of N-(5-methyl-2-furfuryl and-tiophenyl)-dialkyl amines and of 2-dimethylamino methyl-4-(1'-substituted-acetoxy-methyl)-1,3-dioxolanes.
Manfredini S; Guarneri M; Ferroni R; Simoni D; Zaidi JH; Grana E; Boselli C
Drug Des Discov; 1995 Aug; 13(1):1-12. PubMed ID: 8882897
[TBL] [Abstract][Full Text] [Related]
3. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane 3-oxide methiodides.
Romanelli MN; Gualtieri F; Angeli P; Picchio MT
J Med Chem; 1989 Oct; 32(10):2269-73. PubMed ID: 2795598
[TBL] [Abstract][Full Text] [Related]
4. Enantioselectivity of muscarinic antagonists. Isomeric 2-cyclohexyl-2-phenyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides.
Romanelli MN; Gualtieri F; Valle G; Brasili L; Angeli P
J Med Chem; 1988 Sep; 31(9):1703-8. PubMed ID: 3411599
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antimuscarinic properties of some N-substituted 5-(aminomethyl)-3,3-diphenyl-2(3H)-furanones.
Kaiser C; Spagnuolo CJ; Adams TC; Audia VH; Dupont AC; Hatoum H; Lowe VC; Prosser JC; Sturm BL; Noronha-Blob L
J Med Chem; 1992 Nov; 35(23):4415-24. PubMed ID: 1447741
[TBL] [Abstract][Full Text] [Related]
6. 3-(2-Benzofuranyl)quinuclidin-2-ene derivatives: novel muscarinic antagonists.
Nordvall G; Sundquist S; Johansson G; Glas G; Nilvebrant L; Hacksell U
J Med Chem; 1996 Aug; 39(17):3269-77. PubMed ID: 8765510
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and muscarinic activity of a series of tertiary and quaternary N-substituted guvacine esters structurally related to arecoline and arecaidine propargyl ester.
Wolf-Pflugmann M; Lambrecht G; Wess J; Mutschler E
Arzneimittelforschung; 1989 May; 39(5):539-44. PubMed ID: 2757669
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antimuscarinic effects of (-)cis 2,3-dihydro-3-(4-methylpiperazinylmethyl)-2-phenyl-1,5 benzothiazepin-4-(5H)one HCl (BTM-1086) in guinea pig peripheral tissues.
Noronha-Blob L; Sturm BL; Lowe VC; Jackson KN; Kachur JF
Life Sci; 1990; 46(17):1223-31. PubMed ID: 2338887
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and antagonistic activity at muscarinic receptor subtypes of some derivatives of diphenidol.
Varoli L; Angeli P; Buccioni M; Burnelli S; Cavalli A; Marucci G; Recanatini M
Farmaco; 2003 Sep; 58(9):651-7. PubMed ID: 13679157
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antimuscarinic activity of some 1-cycloalkyl-1-hydroxy-1-phenyl-3-(4-substituted piperazinyl)-2-propanones and related compounds.
Kaiser C; Audia VH; Carter JP; McPherson DW; Waid PP; Lowe VC; Noronha-Blob L
J Med Chem; 1993 Mar; 36(5):610-6. PubMed ID: 8496940
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, rotamer orientation, and calcium channel modulation activities of alkyl and 2-phenethyl 1,4-dihydro-2,6-dimethyl-3-nitro-4-(3- or 6-substituted-2-pyridyl)-5-pyridinecarboxylates.
Iqbal N; Akula MR; Vo D; Matowe WC; McEwen CA; Wolowyk MW; Knaus EE
J Med Chem; 1998 May; 41(11):1827-37. PubMed ID: 9599233
[TBL] [Abstract][Full Text] [Related]
12. Stereoselective recognition of the enantiomers of phenglutarimide and of six related compounds by four muscarinic receptor subtypes.
Waelbroeck M; Lazareno S; Pfaff O; Friebe T; Tastenoy M; Mutschler E; Lambrecht G
Br J Pharmacol; 1996 Dec; 119(7):1319-30. PubMed ID: 8968538
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and histamine H2-agonistic activity of ring-substituted phenyl analogues of impromidine.
Buschauer A; Lachenmayr F; Schunack W
Pharmazie; 1991 Dec; 46(12):840-5. PubMed ID: 1687832
[TBL] [Abstract][Full Text] [Related]
14. Antimuscarinic 3-(2-furanyl)quinuclidin-2-ene derivatives: synthesis and structure-activity relationships.
Johansson G; Sundquist S; Nordvall G; Nilsson BM; Brisander M; Nilvebrant L; Hacksell U
J Med Chem; 1997 Nov; 40(23):3804-19. PubMed ID: 9371246
[TBL] [Abstract][Full Text] [Related]
15. Iodoaminopotentidine and related compounds: a new class of ligands with high affinity and selectivity for the histamine H2 receptor.
Hirschfeld J; Buschauer A; Elz S; Schunack W; Ruat M; Traiffort E; Schwartz JC
J Med Chem; 1992 Jun; 35(12):2231-8. PubMed ID: 1613748
[TBL] [Abstract][Full Text] [Related]
16. A new method for evaluating sigma(2) ligand activity in the isolated guinea-pig bladder.
Colabufo NA; Berardi F; Contino M; Perrone R; Tortorella V
Naunyn Schmiedebergs Arch Pharmacol; 2003 Aug; 368(2):106-12. PubMed ID: 12879208
[TBL] [Abstract][Full Text] [Related]
17. Enantioselectivity of muscarinic antagonists. 2,2-Dicyclohexyl-5-[(dimethylamino)methyl]-1,3-oxathiolane methiodides and related 3-oxides.
Romanelli MN; Teodori E; Gualtieri F; Angeli P; Brasili L
J Med Chem; 1988 Sep; 31(9):1698-702. PubMed ID: 3411598
[TBL] [Abstract][Full Text] [Related]
18. The design of novel methoctramine-related tetraamines as muscarinic receptor subtype selective antagonists.
Melchiorre C; Minarini A; Budriesi R; Chiarini A; Spampinato S; Tumiatti V
Life Sci; 1995; 56(11-12):837-44. PubMed ID: 10188783
[TBL] [Abstract][Full Text] [Related]
19. Binding and functional properties of antimuscarinics of the hexocyclium/sila-hexocyclium and hexahydro-diphenidol/hexahydro-sila-diphenidol type to muscarinic receptor subtypes.
Waelbroeck M; Tastenoy M; Camus J; Christophe J; Strohmann C; Linoh H; Zilch H; Tacke R; Mutschler E; Lambrecht G
Br J Pharmacol; 1989 Sep; 98(1):197-205. PubMed ID: 2804545
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological activity of methoctramine-related tetraamines bearing an 11-acetyl-5,11-dihydro-6H-pyrido[2,3-b][1,4] benzodiazepin-6-one moiety: structural requirements for optimum occupancy of muscarinic receptor subtypes as revealed by symmetrical and unsymmetrical polyamines.
Minarini A; Bolognesi ML; Budriesi R; Canossa M; Chiarini A; Spampinato S; Melchiorre C
J Med Chem; 1994 Sep; 37(20):3363-72. PubMed ID: 7932564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
